New bladder cancer treatment to be trialled in UK
An experimental therapy for bladder cancer is predicted to soon be entering Phase I clinical trials in the UK following a development pact signed between Cancer Research UK, its commercial arm Cancer Research Technology, and Sitka Biopharma, a Canadian biotech. Sitka’s therapy (STK-01) is being developed to improve delivery of chemotherapy in non-muscle invasive bladder